High cost of GLP-1s drives some to seek cheaper, unregulated versions
One source
What the source said
PBS News
“High cost of GLP-1s drives some to seek cheaper, unregulated versions”
Despite some recent improvements, millions of Americans still face significant barriers in affording GLP-1s. At the same time, many patients have found alternative, cheaper paths to get their hands on unregulated versions. Stephanie Sy reports for our series, GLP-1s: Reshaping America.
Read at PBS NewsReported by one source so far. It is confirmed when a second, independent source reports the same thing.